BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 18825648)

  • 1. Combination of sodium thiosulphate, cinacalcet, and paricalcitol in the treatment of calciphylaxis with hyperparathyroidism.
    Kyritsis I; Gombou A; Griveas I; Agroyannis I; Retsa K; Agroyannis B
    Int J Artif Organs; 2008 Aug; 31(8):742-4. PubMed ID: 18825648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Calcific uremic arteriolopathy - treatment with sodium thiosulfate].
    Vyskočilová M; Svojanovský J; Blaštíková J; Dvořáková G; Souček M
    Vnitr Lek; 2015 Feb; 61(2):166-72. PubMed ID: 25813263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium thiosulfate, bisphosphonates, and cinacalcet for calciphylaxis.
    Raymond CB; Wazny LD; Sood AR
    CANNT J; 2009; 19(4):25-7; quiz 28-9. PubMed ID: 20136032
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcific uremic arteriolopathy treated with cinacalcet, paricalcitol, and autologous growth factors.
    Kakagia D; Kriki P; Thodis E; Roumeliotis A; Vargemezis V
    J Cutan Med Surg; 2011; 15(2):121-4. PubMed ID: 21477562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calciphylaxis after parathyroidectomy.
    Karmegam S; Shetty A
    Hemodial Int; 2017 Oct; 21 Suppl 2():S62-S66. PubMed ID: 29064176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of sodium thiosulfate in the treatment of calciphylaxis.
    Musso CG; Enz P; Vidal F; Gelman R; Lizarraga A; Giuseppe LD; Kowalczuk A; Garfi L; Galimberti R; Algranati L
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1065-8. PubMed ID: 19861872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcific uremic arteriolopathy while on cinacalcet.
    Gonzalez-Parra E; Martin-Cleary C; Martin J; Ortiz A
    J Postgrad Med; 2011; 57(1):51-2. PubMed ID: 21206121
    [No Abstract]   [Full Text] [Related]  

  • 8. Sodium thiosulfate, bisphosphonates, and cinacalcet for treatment of calciphylaxis.
    Raymond CB; Wazny LD
    Am J Health Syst Pharm; 2008 Aug; 65(15):1419-29. PubMed ID: 18653812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcific uremic arteriolopathy in hemodialyzed patients.
    Checheriţă IA; Smarandache D; Rădulescu D; Peride I; Bratu O; Ciocâlteu A; Sebe I; Lascăr I
    Chirurgia (Bucur); 2013; 108(5):736-40. PubMed ID: 24157123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term intravenous sodium thiosulfate in the treatment of a patient with calciphylaxis.
    Brucculeri M; Cheigh J; Bauer G; Serur D
    Semin Dial; 2005; 18(5):431-4. PubMed ID: 16191185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calciphylaxis and sodium thiosulphate: a glimmer of hope in desperate situation.
    Burnie R; Smail S; Javaid MM
    J Ren Care; 2013 Jun; 39(2):71-6. PubMed ID: 23551819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin wounds associated with calciphylaxis in end-stage renal disease patients on dialysis.
    Sulková SD; Válek M
    Nutrition; 2010 Sep; 26(9):910-4. PubMed ID: 20692603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological control of secondary hyperparathyroidism in hemodialysis subjects: a cost consequences analysis of data from the FARO study.
    Roggeri DP; Mazzaferro S; Brancaccio D; Cannella G; Messa P; Di Luca M; Morosetti M; Costanzo AM; di Luzio Paparatti U; Cornago D; Cozzolino M;
    J Med Econ; 2012; 15(6):1110-7. PubMed ID: 22702445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cutaneous calciphylaxis].
    Wollina U
    Hautarzt; 2010 Dec; 61(12):1063-71; quiz 1072. PubMed ID: 21103856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of sodium thiosulphate in a multi-interventional setting for the treatment of calciphylaxis in dialysis patients.
    Zitt E; König M; Vychytil A; Auinger M; Wallner M; Lingenhel G; Schilcher G; Rudnicki M; Salmhofer H; Lhotta K
    Nephrol Dial Transplant; 2013 May; 28(5):1232-40. PubMed ID: 23291368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sodium thiosulfate--new hope for the treatment of calciphylaxis].
    Heiro M; Mäkelä L; Koivuviita N; Manner I; Tertti R; Hohenthal U; Metsärinne K
    Duodecim; 2011; 127(16):1690-6. PubMed ID: 21972587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effectiveness of paricalcitol versus cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.
    Schumock GT; Walton SM; Lee TA; Marx SE; Audhya P; Andress DL
    Nephron Clin Pract; 2011; 117(2):c151-9. PubMed ID: 20699620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calciphylaxis: no therapeutic concepts for a poorly understood syndrome?
    Meissner M; Gille J; Kaufmann R
    J Dtsch Dermatol Ges; 2006 Dec; 4(12):1037-44. PubMed ID: 17176411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calciphylaxis: a severe complication of renal disease.
    Scola N; Kreuter A
    CMAJ; 2011 Nov; 183(16):1882. PubMed ID: 21844101
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of secondary hyperparathyroidism with paricalcitol with or without cinacalcet in hemodialysis patients.
    Zawierucha J; Małyszko J; Małyszko JS; Prystacki T; Marcinkowski W; Dryl-Rydzyńska T
    Pol Arch Intern Med; 2017 Dec; 127(12):840-845. PubMed ID: 29067991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.